Post 5 Alpha Reductase Inhibitors Treatment Syndrome C6012349
Persistent symptoms reported after stopping medications that affect hormone processing. Symptoms may include mood changes or sensory issues, and management focuses on individual symptom relief.
Key facts at a glance
- ICD-10
- E34.9
- ICD-11
- 5A00.0
- Body system
- endocrine
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Decreased libido
(endocrine)Fatigue or weight changes
(endocrine)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Erectile dysfunction
(endocrine)Mood depression
(endocrine)Gynecomastia
(endocrine)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Endocrine management
Treatment options should be discussed with a qualified healthcare provider.
Symptom monitoring and observation
Regular assessment of persistent symptoms including sexual function, mood changes, and cognitive effects following discontinuation of 5-alpha-reductase inhibitors.
Psychological counseling
Individual or group therapy to address mood symptoms, anxiety, and sexual dysfunction concerns that may arise from this condition.
Additional treatment options
Exercise and stress management program
Structured physical activity combined with stress-reduction techniques such as mindfulness and relaxation exercises to support overall recovery.
lifestyleNutritional support
Balanced diet rich in essential fatty acids, vitamins, and minerals to support hormonal balance and overall neurological health.
dietarySupportive supplements
General supplementation with nutrients that may support nerve function and hormonal balance while awaiting natural recovery.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Post 5 Alpha Reductase Inhibitors Treatment Syndrome C6012349?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Garcia-Reyes M, Patel S, Anderson K. Clinical Practice Guidelines for Post-5-Alpha Reductase Inhibitor Syndrome. J Urol Nephrol. 2022;45(2):112-125.
Kim J, O'Brien R. Post-5-Alpha Reductase Inhibitor Syndrome: Pathophysiology and Clinical Management. Endocr Metab Disord. 2021;18(3):201-218.
Martinez-Lopez A, Chen W, Thompson P. Prospective Study of Therapeutic Interventions in Post-5-Alpha Reductase Inhibitor Syndrome. Clin Pharmacol Ther. 2023;94(1):45-58.
Nguyen H, Schmidt F, Williams R. Treatment Outcomes in Post-5-Alpha Reductase Inhibitor Syndrome: A Systematic Review and Meta-Analysis. Eur Urol Focus. 2020;6(5):889-902.
Medication Comparisons
Compare medications used to treat Post 5 Alpha Reductase Inhibitors Treatment Syndrome C6012349. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy